Roche Science Day – From Idea to Medicine

Mon, 09.10.2017 @09:00
in Hoffmann-La Roche
[add to iCal]

categories:

About the event

The Roche Science Day gives you the opportunity to gain an exclusive insight into how Roche Pharma Research and Development (Roche pRED) drives innovation. You will meet highly recognized researchers at the Basel headquarters and experience Roche pRED first hand.

Roche generously extended an invitation to the D-BSSE. The registration for D-BSSE members runs through our website, and we will forward the registrations to Roche. Registration deadline for this event is Wednesday, the 4th of October.

You can find the detailed agenda below:

08.30 – 09.00 Registration and Welcome

09.00 – 09.10 Welcome and Introduction
Dr. John C. Reed, Global Head of Pharma Research & Early Development (pRED) and Member of the Enlarged Corporate Executive Committee

09.10 – 09.20 This is pRED
Dr. Matthias Nettekoven, Principal Scientist, Medicinal Chemistry

09.20 – 09.50 Disease Therapeutics Areas (DTAs)

  • 09.20 – 09.30 Brain Shuttle
    Dr. Per-Ola Freskgard, Expert Scientist Neuroscience Discovery
  • 09.30 – 09.40 HBV LNA program
    Dr. Timothy Tellinghuisen, Discovery Area Leader, ID Discovery group, I3 DTA
  • 09.40 – 09.50 Oncology
    Dr. James Bischoff, Global Head of Molecular Targeted Therapy – Discovery Oncology

09.50 – 10.10 Large molecule drug discovery
Dr. Stefan Weigand, Global Head Large Molecule Research

10.10 – 10.30 Small molecule drug discovery

  • 10.10 – 10.20 Hit finding / Lead identification
    Dr. Sara Cortese, Global Head of Chemical Biology
  • 10.20 – 10.30 Lead optimization
    Dr. Patrick Schnider, Expert Scientist, Medicinal Chemistry

10.30 – 10.50 Oligonucleotide drug discovery
Dr. Bo Hansen (MBA), Global Head of RNA Therapeutics and General Manager
of Roche Innovation Center Copenhagen

10.50 – 11.05 Break

11.05 – 11.10 Setting the scence
Dr. Matthias Nettekoven, Principal Scientist, Medicinal Chemistry

11.10 – 11.30 Technical development of Small molecules and Oligonucleotide
Dr. Remo Gamboni, Global Head preclinical CMC

11.30 – 11.50 Drug metabolism/Pharmacokinetics
Dr. Lisa Benincosa, Global Head DMPK Development

11.50 – 12.10 Drug safety / toxicology
Dr. Annie Moisan, Principal Scientist at Roche Pharmaceuticals

12.10 – 12.30 Modelling / systems pharmacology
Dr. Thiery Lave, Head DMPK and TOX Project Leaders and
Modeling and Simulation

12.30 – 12.50 Biomarkers
Dr. Corinne Solier, Global Head of Translational Technologies and Bioinformatics

12.50 – 13.40 Networking Lunch (with Roche colleagues from pRED)

13.40 – 14.00 Partnering / Business development
Dr. Maria Bobadilla (MD), Innovation Partnering, Senior Director

14.00 – 14.30 Pathway studies in Pharma: A personal guide
Dr. Johannes Mosbacher, Business Interface Officer

BOOKINGS

Information about the booking process on the "Next Events" tab!

Bookings are closed for this event.